Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial

Researchers determined if Stockholm3 could improve prostate cancer detection in a diverse cohort. An observational prospective multicentered clinical trial, supplemented by prospectively recruited participants in a urology clinic setting included men with suspicion of prostate cancer and underwent prostate biopsy.